Efficacy and safety of finerenone in patients with CKD and type 2 diabetes across the frailty spectrum: a FIDELITY post hoc analysis

被引：0
|
作者：
Rossing, P. [1 ,2 ]
Birkenfeld, A. [3 ,4 ]
Fioretto, P. [5 ]
McGill, J. B. [6 ]
Anker, S. D. [7 ,8 ]
Pitt, B. [9 ]
Scalise, A. [10 ]
Scott, C. [11 ]
Filippatos, G. [12 ]
机构：
[1] Steno Diabet Ctr Copenhagen, Herlev, Denmark
[2] Univ Copenhagen, Copenhagen, Denmark
[3] Univ Clin, Tubingen, Germany
[4] German Ctr Diabet Res, Neuherberg, Germany
[5] Univ Padua, Dept Med, Padua, Italy
[6] Washington Univ, Sch Med, St Louis, MO USA
[7] Charite, Berlin, Germany
[8] Wroclaw Med Univ, Wroclaw, Poland
[9] Univ Michigan, Sch Med, Ann Arbor, MI USA
[10] Bayer Hispania SL, Barcelona, Spain
[11] Bayer PLC, Reading, Berks, England
[12] Natl & Kapodistrian Univ Athens, Athens, Greece
来源：
DIABETOLOGIA | 2024年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
892
引用
收藏
页码：S426 / S427
页数：2
相关论文
共 50 条
  • [31] Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis
    Filippatos, Gerasimos
    Anker, Stefan D.
    August, Phyllis
    Coats, Andrew J. S.
    Januzzi, James L.
    Mankovsky, Boris
    Rossing, Peter
    Ruilope, Luis M.
    Pitt, Bertram
    Sarafidis, Pantelis
    Teerlink, John R.
    Kapelios, Chris J.
    Gebel, Martin
    Brinker, Meike
    Joseph, Amer
    Lage, Andrea
    Bakris, George
    Agarwal, Rajiv
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2023, 9 (02) : 183 - 191
  • [32] Safety and efficacy of empagliflozin in elderly Japanese patients with type 2 diabetes mellitus: A post hoc analysis of data from the SACRA study
    Okada, Kenta
    Hoshide, Satoshi
    Kato, Mitsutoshi
    Kanegae, Hiroshi
    Ishibashi, Shun
    Kario, Kazuomi
    JOURNAL OF CLINICAL HYPERTENSION, 2021, 23 (04): : 860 - 869
  • [33] Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
    Agarwal, Rajiv
    Filippatos, Gerasimos
    Pitt, Bertram
    Anker, Stefan D.
    Rossing, Peter
    Joseph, Amer
    Kolkhof, Peter
    Nowack, Christina
    Gebel, Martin
    Ruilope, Luis M.
    Bakris, George L.
    EUROPEAN HEART JOURNAL, 2022, 43 (06) : 474 - +
  • [34] Effect of finerenone in patients with chronic kidney disease and type 2 diabetes by baseline anaemia status: a FIDELITY analysis
    Singh, A.
    Anker, S. D.
    Filippatos, G.
    Pitt, B.
    Rossing, P.
    Ruilope, L. M.
    Farjat, A. E.
    James, G.
    Farag, Y. M. K.
    Roberts, L.
    Bakris, G.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [35] OUTCOMES WITH FINERENONE IN PATIENTS WITH STAGE 4 CHRONIC KIDNEY DISEASE AND TYPE 2 DIABETES: A FIDELITY SUBGROUP ANALYSIS
    Sarafidis, Pantelis
    Ruilope, Luis
    Anker, Stefan D.
    Agarwal, Rajiv
    Pitt, Bertram
    Filippatos, Gerasimos
    Rossing, Peter
    Tuttle, Katherine
    Boletis, Ioannis
    Toto, Robert
    Wanner, Christoph
    Liu Zhi-Hong
    Ahlers, Christiane
    Brinker, Meike
    Lawatscheck, Robert
    Joseph, Amer
    Bakris, George
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I134 - I135
  • [36] Efficacy and Cardiovascular Safety of Linagliptin as an Add-On to Insulin in Type 2 Diabetes: A Pooled Comprehensive Post Hoc Analysis
    Zinman, Bernard
    Ahren, Bo
    Neubacher, Dietmar
    Patel, Sanjay
    Woerle, Hans-Juergen
    Johansen, Odd Erik
    CANADIAN JOURNAL OF DIABETES, 2016, 40 (01) : 50 - 57
  • [37] Finerenone in Patients across the Spectrum of CKD and T2D by GLP-1RA Use
    Rossing, Peter
    Anker, Stefan
    Filippatos, Gerasimos
    Pitt, Bertram
    Ruilope, Luis M.
    Fonseca, Vivian
    Umpierrez, Guillermo E.
    Caramori, Luiza
    Lambelet, Marc
    Viswanathan, Prabhakar
    Lawatscheck, Robert
    Joseph, Amer
    Bakris, George
    DIABETES, 2022, 71
  • [38] A post hoc analysis of saxagliptin efficacy and safety in patients with type 2 diabetes stratified by UKPDS 10-year cardiovascular risk score
    Bonora, E.
    Bryzinski, B.
    Hirshberg, B.
    Cook, W.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2016, 26 (05) : 374 - 379
  • [39] Efficacy of Dulaglutide as a First Injectable Option for Patients with Type 2 Diabetes: A Post-Hoc Pooled Analysis
    Patel, Hiren
    Munir, Kashif
    Sutherland, Sindee
    Karanikas, Chrisanthi A.
    Konig, Manige
    DIABETES THERAPY, 2019, 10 (06) : 2321 - 2330
  • [40] Air pollution exposure and effect of finerenone treatment in patients with chronic kidney disease and type 2 diabetes: A FIDELITY analysis
    Al-Kindi, Sadeer
    Chen, Zhuo
    Dazard, Jean-Eudes
    Farag, Youssef
    Filippatos, Gerasimos
    Rossing, Peter
    Rohwedder, Katja
    Salerno, Pedro
    Scott, Charlie
    Zheng, Zihe
    Rajagopalan, Sanjay
    CIRCULATION, 2024, 150
12345